CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia

AM Alayoubi, ZY Khawaji, MA Mohammed… - Annals of …, 2024 - Springer
Gene therapy represents a significant potential to revolutionize the field of hematology with
applications in correcting genetic mutations, generating cell lines and animal models, and …
被引用次数：2 相关文章

CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia

AM Alayoubi, ZY Khawaji, MA Mohammed… - Annals of … - pubmed.ncbi.nlm.nih.gov
Gene therapy represents a significant potential to revolutionize the field of hematology with
applications in correcting genetic mutations, generating cell lines and animal models, and …

CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia.

AM Alayoubi, ZY Khawaji, MA Mohammed… - Annals of …, 2023 - europepmc.org
Gene therapy represents a significant potential to revolutionize the field of hematology with
applications in correcting genetic mutations, generating cell lines and animal models, and …